Business

Exploring the intersection of finance, pharma, and biotech

Biotech By Allison DeAngelis

Despite biotech slump, veterans of SVB and KKR launch investment firm

Enavate, started by alumni of SVB and KKR, will encourage treatment of specific diseases.

Read The Story

Business By Bob Herman

The doctor who is trying to bring back surprise billing

Health By Olivia Goldhill

‘It’s not medical’: Oregon wrestles with how to offer psychedelics outside the health care system

Business By Allison Bond

A ‘Shark Tank’-funded test for food sensitivity is medically dubious, experts say

Business By Rebecca Robbins

Anxious about a big speech? This startup wants to calm you down — with a cardiac drug you pop like a mint

All Coverage

Business By Andrew Joseph

‘We are not casting a wide enough net’: Rob Perez on how biopharma companies can help out their neighbors

Business By Tara Bannow

A hospital lobbying juggernaut makes an unlikely pivot into venture capital

Business By Bob Herman

TeamHealth hit with another lawsuit for alleged overbilling, this time from an employer

Business By Bob Herman

The biggest PBMs are handling more and more of the country’s drug price negotiations

Business By Bob Herman

Patients are flocking back to hospitals, but volumes are at the mercy of Covid surges, new documents show

SurpriseHospitalBills_Illustration_MollyFerguson_030722

Business By Bob Herman

A glaring gap in Congress’ surprise billing law leaves patients on the hook for pricey, out-of-network lab tests

Business By Bob Herman

Even as it struggles, startup insurer Bright Health deepens its ties to Cigna

Travel nurse El Paso, traveling nurse Patricia Carrete

Business By Rachel Cohrs

Private equity firms are cashing in on the travel nursing business that has boomed during the pandemic

Exclusive By Rachel Cohrs

The Catholic hospital system Ascension is running a Wall Street-style private equity fund

A STAT Investigation By Rachel Cohrs

How America’s largest Catholic hospital system is moonlighting as a private equity firm

Pharma By Olivia Goldhill

Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property

A STAT Investigation By Eric Boodman

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?

By Jonathan Saltzman — Boston Globe

Lawyers for Henrietta Lacks estate say more companies to be sued over use of her cells

Business By Andrew Joseph

Third member of FDA expert committee resigns over controversial Alzheimer’s therapy decision

Business By Andrew Joseph

Member of FDA’s expert panel resigns over controversial Alzheimer’s therapy approval

Exclusive By Adam Feuerstein and Damian Garde

Martin Shkreli’s longtime friend wants to undo his 4,000% price hike. But first he’ll have to finally oust the ‘pharma bro’

Business By Alicia Diaz

Medical device firms’ payments to doctors far outstripped those from pharma, study shows

Hospitals By Liz Kowalczyk, Sarah L. Ryley, Mark Arsenault, and Patricia Wen — Boston Globe

Boston’s hospital chiefs moonlight on corporate boards at rates far beyond the national level

Pharma By Olivia Goldhill

Behind the scenes, companies helping big Covid-19 vaccine makers are getting rich

By Casey Ross and Erin Brodwin

‘What was left for Haven?’: How Amazon’s health ambitions devoured Haven’s plans

Health Tech By Elizabeth Cooney

As health tech flourished, Teladoc and Livongo saw an opportunity to ‘accelerate,’ executives say

Biotech By Elizabeth Cooney

Foundation Medicine wins FDA approval for liquid biopsy able to detect mutations in multiple cancers

Biotech By Adam Feuerstein

The FDA accepted Biogen’s Alzheimer’s drug submission. Next up, a highly anticipated outside expert review

Biotech By Damian Garde and Matthew Herper

Despite biotech slump, veterans of SVB and KKR launch investment firm

The doctor who is trying to bring back surprise billing

‘It’s not medical’: Oregon wrestles with how to offer psychedelics outside the health care system

A ‘Shark Tank’-funded test for food sensitivity is medically dubious, experts say

Anxious about a big speech? This startup wants to calm you down — with a cardiac drug you pop like a mint

All Coverage

‘We are not casting a wide enough net’: Rob Perez on how biopharma companies can help out their neighbors

A hospital lobbying juggernaut makes an unlikely pivot into venture capital

TeamHealth hit with another lawsuit for alleged overbilling, this time from an employer

The biggest PBMs are handling more and more of the country’s drug price negotiations

Patients are flocking back to hospitals, but volumes are at the mercy of Covid surges, new documents show

A glaring gap in Congress’ surprise billing law leaves patients on the hook for pricey, out-of-network lab tests

Even as it struggles, startup insurer Bright Health deepens its ties to Cigna

Private equity firms are cashing in on the travel nursing business that has boomed during the pandemic

The Catholic hospital system Ascension is running a Wall Street-style private equity fund

How America’s largest Catholic hospital system is moonlighting as a private equity firm

Latest psilocybin patent highlights the swirling battle over psychedelics intellectual property

Selling certainty: In a sea of skeptics, this physician was one of fibromyalgia patients' few true allies. Or was he?

Lawyers for Henrietta Lacks estate say more companies to be sued over use of her cells

Third member of FDA expert committee resigns over controversial Alzheimer’s therapy decision

Member of FDA’s expert panel resigns over controversial Alzheimer’s therapy approval

Martin Shkreli’s longtime friend wants to undo his 4,000% price hike. But first he’ll have to finally oust the ‘pharma bro’

Medical device firms’ payments to doctors far outstripped those from pharma, study shows

Boston’s hospital chiefs moonlight on corporate boards at rates far beyond the national level

Behind the scenes, companies helping big Covid-19 vaccine makers are getting rich

‘What was left for Haven?’: How Amazon’s health ambitions devoured Haven’s plans

As health tech flourished, Teladoc and Livongo saw an opportunity to ‘accelerate,’ executives say

Foundation Medicine wins FDA approval for liquid biopsy able to detect mutations in multiple cancers

The FDA accepted Biogen’s Alzheimer’s drug submission. Next up, a highly anticipated outside expert review

Coles-led Cerevel Therapeutics to raise $445 million to develop brain drugs with fewer side effects

Subscribe to STAT for $15 per month lorem ipsum